Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. External Links
  9. Analytics And Tracking
  10. Libraries
  11. Hosting Providers
  12. CDN Services

We began analyzing https://onlinelibrary.wiley.com/doi/10.1111/imr.12518, but it redirected us to https://onlinelibrary.wiley.com/doi/10.1111/imr.12518. The analysis below is for the second page.

Title[redir]:
TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy - Dougall - 2017 - Immunological Reviews - Wiley Online Library
Description:
While therapies targeting the co-inhibitory or immune checkpoint receptors PD-1 and CTLA-4 have shown remarkable success in many cancers, not all patients benefit from these therapies. This has catal...

Matching Content Categories {📚}

  • Telecommunications
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure if the website is profiting.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Doi.org might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

immune, checkpoint, wiley, tigit, receptors, technologies, cookies, article, receptor, text, therapies, targeting, cell, support, privacy, policy, skip, information, search, targets, cancer, immunotherapy, march, full, pdf, pathway, data, references, related, training, rights, website, utilizes, enable, essential, site, functionality, analytics, personalization, targeted, advertising, learn, view, link, content, journal, term, login, register, immunological,

Topics {✒️}

cancer immunotherapy william ligand affinities fine-tune article information search privacy policy skip accumulating data support checkpoint receptor targets immune checkpoint receptors shown remarkable success catalyzed enormous interest website utilizes technologies article content skip artificial intelligence technologies related companies support contact cd28/ctla-4 pathway full text wiley immune response checkpoint inhibitors differential receptor cookies similar technologies article hosted data mining targeted advertising sema kurtulus therapies targeting patients benefit recently entered shared ligands clear understanding rights reserved including rights unavailable due technical difficulties cell text therapies tigit receptors ctla-4 pathway targeting analytics personalization learn view link journal cd96

External Links {🔗}(258)

Analytics and Tracking {📊}

  • Facebook Pixel
  • Site Verification - Google

Libraries {📚}

  • Dropzone.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Confiant-integrations

3.07s.